Seegene Financial Statements From 2010 to 2024
| 096530 Stock | KRW 23,150 50.00 0.22% |
Check Seegene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Seegene's main balance sheet or income statement drivers, such as , as well as many indicators such as . Seegene financial statements analysis is a perfect complement when working with Seegene Valuation or Volatility modules.
Seegene |
Seegene Company Current Valuation Analysis
Seegene's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Seegene Current Valuation | 3.51 T |
Most of Seegene's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seegene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Seegene has a Current Valuation of 3.51 T. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
Seegene Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Seegene's current stock value. Our valuation model uses many indicators to compare Seegene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seegene competition to find correlations between indicators driving Seegene's intrinsic value. More Info.Seegene is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.52 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Seegene is roughly 1.92 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Seegene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Seegene's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Seegene Financial Statements
Seegene stakeholders use historical fundamental indicators, such as Seegene's revenue or net income, to determine how well the company is positioned to perform in the future. Although Seegene investors may analyze each financial statement separately, they are all interrelated. For example, changes in Seegene's assets and liabilities are reflected in the revenues and expenses on Seegene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Seegene. Please read more on our technical analysis and fundamental analysis pages.
Seegene, Inc. manufactures and sells molecular diagnostics systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea. SEEGENE is traded on Korean Securities Dealers Automated Quotations in South Korea.
Other Information on Investing in Seegene Stock
Seegene financial ratios help investors to determine whether Seegene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seegene with respect to the benefits of owning Seegene security.